Cargando…

Clinical Characteristics and Outcomes of Patients with Lung Cancer and Venous Thromboembolism

Background The natural history of patients with lung cancer and venous thromboembolism (VTE) has not been consistently evaluated. Methods We used the RIETE (Registro Informatizado Enfermedad TromboEmbólica) database to assess the clinical characteristics, time course, and outcomes during anticoagu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruiz-Artacho, Pedro, Trujillo-Santos, Javier, López-Jiménez, Luciano, Font, Carme, Díaz-Pedroche, María del Carmen, Sánchez Muñoz-Torrero, Juan Francisco, Peris, Maria Luisa, Skride, Andris, Maestre, Ana, Monreal, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2018
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524875/ https://www.ncbi.nlm.nih.gov/pubmed/31249944 http://dx.doi.org/10.1055/s-0038-1656542

Ejemplares similares

Cancer Histology and Natural History of Patients with Lung Cancer and Venous Thromboembolism
por: Ruiz-Artacho, Pedro, et al.
Publicado: (2022)

Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores
por: Lecumberri, Ramón, et al.
Publicado: (2021)

Acute venous thromboembolism in patients with brain cancer: clinical course
por: Becattini, Cecilia, et al.
Publicado: (2023)

Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism
por: Martínez-Urbistondo, Diego, et al.
Publicado: (2021)

Analysis of clinical factors affecting the rates of fatal pulmonary embolism and bleeding in cancer patients with venous thromboembolism
por: Trujillo-Santos, Javier, et al.
Publicado: (2017)

Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry
por: Borjas Howard, Jaime, et al.
Publicado: (2021)

Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism
por: Farge, Dominique, et al.
Publicado: (2015)

Validation of a prognostic score for hidden cancer in unprovoked venous thromboembolism
por: Jara-Palomares, Luis, et al.
Publicado: (2018)

Systematic testing for venous thromboembolism in hospitalized patients with COVID-19 and raised D-dimer levels
por: Weinberg, Ido, et al.
Publicado: (2021)

Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?
por: Mahé, Isabelle, et al.
Publicado: (2015)

Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?
por: Camporese, Giuseppe, et al.
Publicado: (2020)

Venous Thromboembolism Recurrence in Latvian Population: Single University Hospital Data
por: Ģībietis, Valdis, et al.
Publicado: (2019)

Clinical guide SEOM on venous thromboembolism in cancer patients
por: Muñoz Martín, A. J., et al.
Publicado: (2014)

Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
por: Trujillo‐Santos, Javier, et al.
Publicado: (2022)

PICO Questions and DELPHI Methodology for the Management of Venous Thromboembolism Associated with COVID-19
por: Riera-Mestre, Antoni, et al.
Publicado: (2021)

Risk profile, management, and outcomes of patients with venous thromboembolism attended in Spanish Emergency Departments: The ESPHERIA registry
por: Jimenez, Sonia, et al.
Publicado: (2017)

Baseline Clinical Characteristics and Incidence of Chronic Thromboembolic Pulmonary Hypertension Patients in Latvia, 2019–2020
por: Kauliņš, Ričards, et al.
Publicado: (2023)

Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry
por: Riera-Mestre, Antoni, et al.
Publicado: (2019)

Pharmacological cancer treatment and venous thromboembolism risk
por: Muñoz Martín, Andrés J, et al.
Publicado: (2020)

Outcomes beyond the Third Month of Anticoagulation in Patients Aged >75 Years with a First Episode of Unprovoked Venous Thromboembolism
por: Iñurrieta, Amaia, et al.
Publicado: (2018)

Saddle Pulmonary Embolism in Patients with Cancer in the Era of Incidental Events: Clinical Findings and Outcomes in a Single Centre Cohort
por: Aramberri, Mario, et al.
Publicado: (2022)

Saddle Pulmonary Embolism in Patients with Cancer in the Era of Incidental Events: Clinical Findings and Outcomes in a Single Centre Cohort
por: Aramberri, Mario, et al.
Publicado: (2022)

Clinical Differences and Outcomes of COVID-19 Associated Pulmonary Thromboembolism in Comparison with Non-COVID-19 Pulmonary Thromboembolism
por: de Cossio, Santiago, et al.
Publicado: (2022)

Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer
por: Muñoz Martín, Andrés J., et al.
Publicado: (2018)

Chronic Thromboembolic Pulmonary Hypertension and Antiphospholipid Syndrome with Immune Thrombocytopenia: A Case Report
por: Skride, Andris, et al.
Publicado: (2018)

Cancer-Associated Thrombosis: Beyond Clinical Practice Guidelines—A Multidisciplinary (SEMI–SEOM–SETH) Expert Consensus
por: Pachón, Vanessa, et al.
Publicado: (2018)

Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project
por: Tafur, Alfonso, et al.
Publicado: (2020)

Association between long travel and venous thromboembolic disease: a systematic review and meta-analysis of case-control studies
por: Trujillo-Santos, A. Javier, et al.
Publicado: (2007)

COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding
por: Demelo-Rodriguez, Pablo, et al.
Publicado: (2023)

Accuracy of the Ottawa score in risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism: a systematic review and meta-analysis
por: Delluc, Aurélien, et al.
Publicado: (2020)

Cellular Indices and Outcome in Patients with Acute Venous Thromboembolism
por: Siddiqui, Fakiha, et al.
Publicado: (2022)

Incidence of venous thromboembolism in patients with non-hematological cancer admitted for COVID-19 at a third-level hospital in Madrid
por: Paredes-Ruiz, Diana, et al.
Publicado: (2021)

Platelet Count and Bleeding in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism: Lesson from the RIETE Registry
por: Di Micco, Pierpaolo, et al.
Publicado: (2019)

A Case-Control Analysis of the Impact of Venous Thromboembolic Disease on Quality of Life of Patients with Cancer: Quality of Life in Cancer (Qca) Study
por: Marin-Barrera, Lucia, et al.
Publicado: (2019)

Venous thromboembolism /
por: Hirsh, Jack, 1935-
Publicado: (1981)

Sex Differences in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism
por: Blanco-Molina, Angeles, et al.
Publicado: (2014)

Review of the cost of venous thromboembolism
por: Fernandez, Maria M, et al.
Publicado: (2015)

Venous thromboembolism prophylaxis on flights
por: Marques, Marcos Arêas, et al.
Publicado: (2018)

Management of Venous Thromboembolism: Recent Advances in Oral Anticoagulation Therapy
por: Finks, Shannon W., et al.
Publicado: (2016)

Chronic Thromboembolic Pulmonary Hypertension Mimicking Acute Pulmonary Embolism: A Case Report
por: Kaulins, Ricards, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pm7vq70t4ndi1l0uekk1niphs1